Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Burden of Illness in Hereditary Angioedema: A Conceptual Model.

Bygum A, Aygören-Pürsün E, Beusterien K, Hautamaki E, Sisic Z, Wait S, Boysen HB, Caballero T.

Acta Derm Venereol. 2015 Jun 24;95(6):706-10. doi: 10.2340/00015555-2014.

2.

Canadian hereditary angioedema guideline.

Betschel S, Badiou J, Binkley K, Hébert J, Kanani A, Keith P, Lacuesta G, Yang B, Aygören-Pürsün E, Bernstein J, Bork K, Caballero T, Cicardi M, Craig T, Farkas H, Longhurst H, Zuraw B, Boysen H, Borici-Mazi R, Bowen T, Dallas K, Dean J, Lang-Robertson K, Laramée B, Leith E, Mace S, McCusker C, Moote B, Poon MC, Ritchie B, Stark D, Sussman G, Waserman S.

Allergy Asthma Clin Immunol. 2014 Oct 24;10(1):50. doi: 10.1186/1710-1492-10-50. eCollection 2014.

3.

Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe.

Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Wait S, Boysen HB, Caballero T.

Orphanet J Rare Dis. 2014 Jul 4;9:99. doi: 10.1186/1750-1172-9-99.

4.

The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe.

Caballero T, Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Wait S, Boysen HB.

Allergy Asthma Proc. 2014 Jan-Feb;35(1):47-53. doi: 10.2500/aap.2013.34.3685. Epub 2013 Nov 22.

PMID:
24268449
5.

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study.

Martinez-Saguer I, Cicardi M, Suffritti C, Rusicke E, Aygören-Pürsün E, Stoll H, Rossmanith T, Feussner A, Kalina U, Kreuz W.

Transfusion. 2014 Jun;54(6):1552-61. doi: 10.1111/trf.12501. Epub 2013 Nov 24.

6.

Risk of angioedema following invasive or surgical procedures in HAE type I and II--the natural history.

Aygören-Pürsün E, Martinez Saguer I, Kreuz W, Klingebiel T, Schwabe D.

Allergy. 2013 Aug;68(8):1034-9. doi: 10.1111/all.12186.

7.

Challenges of C1-inhibitor concentrate self-administration.

Boysen HB, Bouillet L, Aygören-Pürsün E.

Int Arch Allergy Immunol. 2013;161 Suppl 1:21-5. doi: 10.1159/000351238. Epub 2013 May 28.

PMID:
23689241
8.

WAO Guideline for the Management of Hereditary Angioedema.

Craig T, Aygören-Pürsün E, Bork K, Bowen T, Boysen H, Farkas H, Grumach A, Katelaris CH, Lockey R, Longhurst H, Lumry W, Magerl M, Martinez-Saguer I, Ritchie B, Nast A, Pawankar R, Zuraw B, Maurer M.

World Allergy Organ J. 2012 Dec;5(12):182-99. doi: 10.1097/WOX.0b013e318279affa.

9.

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology.

Bygum A, Aygören-Pürsün E, Caballero T, Beusterien K, Gholizadeh S, Musingarimi P, Wait S, Boysen H.

BMC Dermatol. 2012 Apr 26;12:4. doi: 10.1186/1471-5945-12-4.

10.

Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema.

Kreuz W, Rusicke E, Martinez-Saguer I, Aygören-Pürsün E, Heller C, Klingebiel T.

Transfusion. 2012 Jan;52(1):100-7. doi: 10.1111/j.1537-2995.2011.03240.x. Epub 2011 Jul 14.

PMID:
21756262
11.

Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies.

Gower RG, Busse PJ, Aygören-Pürsün E, Barakat AJ, Caballero T, Davis-Lorton M, Farkas H, Hurewitz DS, Jacobs JS, Johnston DT, Lumry W, Maurer M.

World Allergy Organ J. 2011 Feb;4(2 Suppl):S9-S21. doi: 10.1097/WOX.0b013e31821359a2.

12.

HAE international home therapy consensus document.

Longhurst HJ, Farkas H, Craig T, Aygören-Pürsün E, Bethune C, Bjorkander J, Bork K, Bouillet L, Boysen H, Bygum A, Caballero T, Cicardi M, Dempster J, Gompels M, Gooi J, Grigoriadou S, Huffer U, Kreuz W, Levi MM, Long J, Martinez-Saguer I, Raguet M, Reshef A, Bowen T, Zuraw B.

Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):22. doi: 10.1186/1710-1492-6-22.

13.

On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience.

Aygören-Pürsün E, Martinez-Saguer I, Rusicke E, Klingebiel T, Kreuz W.

Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):21. doi: 10.1186/1710-1492-6-21.

14.

Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate.

Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, Heller C, Klingebiel T, Kreuz W.

Am J Obstet Gynecol. 2010 Aug;203(2):131.e1-7. doi: 10.1016/j.ajog.2010.03.003. Epub 2010 May 14.

PMID:
20471627
15.

Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.

Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, von Hentig N, Klingebiel T, Kreuz W.

Transfusion. 2010 Feb;50(2):354-60. doi: 10.1111/j.1537-2995.2009.02394.x. Epub 2009 Sep 24.

PMID:
19788511
16.

C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.

Kreuz W, Martinez-Saguer I, Aygören-Pürsün E, Rusicke E, Heller C, Klingebiel T.

Transfusion. 2009 Sep;49(9):1987-95. doi: 10.1111/j.1537-2995.2009.02230.x. Epub 2009 May 20.

PMID:
19497056
17.

Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema.

Gösswein T, Kocot A, Emmert G, Kreuz W, Martinez-Saguer I, Aygören-Pürsün E, Rusicke E, Bork K, Oldenburg J, Müller CR.

Cytogenet Genome Res. 2008;121(3-4):181-8. doi: 10.1159/000138883. Epub 2008 Aug 28.

PMID:
18758157
18.

Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.

Wagenaar-Bos IG, Drouet C, Aygören-Pursun E, Bork K, Bucher C, Bygum A, Farkas H, Fust G, Gregorek H, Hack CE, Hickey A, Joller-Jemelka HI, Kapusta M, Kreuz W, Longhurst H, Lopez-Trascasa M, Madalinski K, Naskalski J, Nieuwenhuys E, Ponard D, Truedsson L, Varga L, Nielsen EW, Wagner E, Zingale L, Cicardi M, van Ham SM.

J Immunol Methods. 2008 Sep 30;338(1-2):14-20. doi: 10.1016/j.jim.2008.06.004. Epub 2008 Jul 23.

PMID:
18655790
19.

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, Farkas H, Varga L, Zingale LC, Binkley K, Wagner E, Adomaitis P, Brosz K, Burnham J, Warrington R, Kalicinsky C, Mace S, McCusker C, Schellenberg R, Celeste L, Hebert J, Valentine K, Poon MC, Serushago B, Neurath D, Yang W, Lacuesta G, Issekutz A, Hamed A, Kamra P, Dean J, Kanani A, Stark D, Rivard GE, Leith E, Tsai E, Waserman S, Keith PK, Page D, Marchesin S, Longhurst HJ, Kreuz W, Rusicke E, Martinez-Saguer I, Aygören-Pürsün E, Harmat G, Füst G, Li H, Bouillet L, Caballero T, Moldovan D, Späth PJ, Smith-Foltz S, Nagy I, Nielsen EW, Bucher C, Nordenfelt P, Xiang ZY.

Ann Allergy Asthma Immunol. 2008 Jan;100(1 Suppl 2):S30-40. Review.

PMID:
18220150
20.

Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions.

Aygören-Pürsün E, Martinez Saguer I, Rusicke E, Louwen F, Geka F, Ivaskevicius V, Oldenburg J, Klingebiel T, Kreuz W.

Am J Hematol. 2007 Apr;82(4):317-20.

PMID:
17034026
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk